[
    [
        {
            "time": "",
            "original_text": "疫苗数据引爆全球市场，A股市场怎么走？",
            "features": {
                "keywords": [
                    "疫苗",
                    "数据",
                    "全球市场",
                    "A股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗数据引爆全球市场，A股市场怎么走？",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "中信证券：BNT162b2新冠疫苗结果超预期，有望为相关企业业绩带来较大弹性",
            "features": {
                "keywords": [
                    "中信证券",
                    "BNT162b2",
                    "新冠疫苗",
                    "超预期",
                    "业绩弹性"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中信证券：BNT162b2新冠疫苗结果超预期，有望为相关企业业绩带来较大弹性",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "中信证券：BNT162b2新冠疫苗结果超预期 有望为相关企业业绩带来较大弹性",
            "features": {
                "keywords": [
                    "中信证券",
                    "BNT162b2",
                    "新冠疫苗",
                    "超预期",
                    "业绩弹性"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中信证券：BNT162b2新冠疫苗结果超预期 有望为相关企业业绩带来较大弹性",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：与合作方共同合作研发的新型冠状病毒mRNA疫苗目前处于一期临床试验阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "一期临床试验"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：与合作方共同合作研发的新型冠状病毒mRNA疫苗目前处于一期临床试验阶段",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]